Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
View on ClinicalTrials.gov
Summary
The Serpentine (Stratify cancER PatiENTs by ImmuNosupprEssion) project, represents the most consistent effort so far attempted to translate MDSC into clinical practise by producing an off-the-shelf compliant assay for quantifying these cells in peripheral blood.
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2022-03-10
Completion Date
2026-12-31
Last Updated
2025-05-02
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
MDSC quantification
Blood sample will be collected at baseline and during therapy, and, optionally, in case of disease progression (PD).
Locations (1)
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy